Reports 11.5% YoY B2B ARR Increase and ARR of
Fiscal First Quarter 2027 Summary (compared to prior-year quarter)
- B2B ARR grew
$1.7 million or 11.5% compared to the first quarter of fiscal 2026 resulting in$16.5 million of ARR. This included AI related ARR of$1.1 million which grew 38% sequentially from the fourth quarter of fiscal 2026. - Platform revenue up 3.7% to $5.3 million. Annual Recurring Revenue ("ARR") up 5.7% to $22.5 million, which includes approximately
$16.5 million of B2B recurring revenue and$6.0 million of B2C recurring revenue. - Total revenue of
$11.9 million , compared to$12.3 million . - Gross profit of
$6.4 million compared to$6.2 million . Total gross margin improved 300 basis points to 53.6%, driven mainly by the continued platform mix shift and improved transaction margins. - Net income of
$765,000 , or$0.02 per diluted share, compared to$749,000 or$0.02 per diluted share. Adjusted net income after excluding one-time items was$1.2 million or$0.04 per diluted share. - Adjusted EBITDA of
$1.0 million and an adjusted EBITDA margin of 8.6%. Adjusted EBITDA after excluding one-time items was$1.5 million . - Cash flow from operations of
$1.2 million compared to$1.1 million in the prior year. The Company ended the quarter with$12.6 million in cash and cash equivalents after paying$1.2 million of the Scite earn-out.
"Our continued investment in innovation is expanding how researchers discover, access, and engage with scientific literature," said
Fiscal First Quarter 2027 Results
Total revenue was
Platform subscription revenue for the quarter was
Transaction revenue was
Total gross margin improved 300 basis points from the prior-year quarter to 53.6%. The increase was primarily driven by the continued revenue mix shift to the higher-margin platforms business and an improvement in transactions gross margin to 26.7% from 23.8%, partially offset by a lower Platforms gross margin on slightly higher hosting and technology costs.
Total operating expenses were
Other expense for the quarter was approximately
Net income in the first quarter was
Conference Call
Date:
Time:
Dial-in number: 1-203-518-9765
Conference ID: RESEARCH
The conference call will be broadcast live and available for replay until
| Fiscal First Quarter Financial and Operational Summary Tables vs. | ||||||
| | | | | | | |
| | | | Quarter Ended | |||
| | | | 2026 | 2025 | Change | % Change |
| | Revenue: | | | | | |
| | | Platforms | $ 5,309,780 | $ 5,120,840 | $ 188,940 | 3.7 % |
| | | Transactions | 6,601,733 | 7,191,345 | (589,612) | -8.2 % |
| | Total Revenue | 11,911,513 | 12,312,185 | (400,672) | -3.3 % | |
| | | | | | | |
| | Gross Profit: | | | | | |
| | | Platforms | 4,621,522 | 4,510,465 | 111,057 | 2.5 % |
| | | Transactions | 1,759,458 | 1,714,833 | 44,625 | 2.6 % |
| | Total Gross Profit | 6,380,980 | 6,225,298 | 155,682 | 2.5 % | |
| | | | | | | |
| | Gross profit as a % of revenue: | | | | | |
| | | Platforms | 87.0 % | 88.1 % | -1.0 % | |
| | | Transactions | 26.7 % | 23.8 % | 2.8 % | |
| | Total Gross Profit | 53.6 % | 50.6 % | 3.0 % | | |
| | | | | | | |
| | Operating Expenses: | | | | | |
| | | Sales and marketing | 1,463,197 | 1,666,825 | (203,628) | -12.2 % |
| | | Technology and product development | 1,665,892 | 1,410,151 | 255,741 | 18.1 % |
| | | General and administrative | 2,225,243 | 1,675,359 | 549,884 | 32.8 % |
| | | Depreciation and amortization | 310,863 | 316,066 | (5,203) | -1.6 % |
| | | Stock-based compensation | (196,549) | 212,482 | (409,031) | -192.5 % |
| | | Foreign currency translation loss (gain) | (8,541) | (17,256) | 8,715 | -50.5 % |
| | Total Operating Expenses | 5,460,105 | 5,263,627 | 196,478 | 3.7 % | |
| | Income (loss) from operations | 920,875 | 961,671 | (40,796) | -4.2 % | |
| | | | | | | |
| | Other Income (Expenses): | | | | | |
| | | Other income (expenses) | (55,604) | (191,053) | 135,449 | NM |
| | | Provision for income taxes | (100,019) | (21,231) | (78,788) | 371.1 % |
| | Total Other Income (Expenses): | (155,623) | (212,284) | 56,661 | NM | |
| | Net income (loss) | $ 765,252 | $ 749,387 | 15,865 | 2.1 % | |
| | | | | | | |
| | Adjusted EBITDA | $ 1,026,648 | $ 1,472,963 | $ (446,315) | -30.3 % | |
| | | | | | | |
| | | | Quarter Ended | |||
| | | | 2026 | 2025 | Change | % Change |
| | Platforms: | | | | | |
| | | B2B ARR (Annual recurring revenue): | | | | |
| | | Beginning of Period | $ 16,202,626 | $ 14,197,598 | $ 2,005,028 | 14.1 % |
| | | Incremental ARR | $ 257,415 | 560,874 | (303,459) | -54.1 % |
| | | End of Period | $ 16,460,041 | $ 14,758,472 | $ 1,701,569 | 11.5 % |
| | | | | | | |
| | | Deployments: | | | | |
| | | Beginning of Period | 1,276 | 1,171 | 105 | 9.0 % |
| | | Incremental Deployments | 22 | 14 | 8 | 57.1 % |
| | | End of Period | 1,298 | 1,185 | 113 | 9.5 % |
| | | | | | | |
| | | ASP (Average sales price): | | | | |
| | | Beginning of Period | $ 12,698 | $ 12,124 | $ 574 | 4.7 % |
| | | End of Period | $ 12,681 | $ 12,454 | $ 227 | 1.8 % |
| | | | | | | |
| | | B2C ARR (Annual recurring revenue): | | | | |
| | | Beginning of Period | $ 6,342,350 | $ 6,721,356 | $ (379,006) | -5.6 % |
| | | Incremental ARR | (298,571) | (186,159) | (112,412) | NM |
| | | End of Period | $ 6,043,779 | $ 6,535,197 | $ (491,418) | -7.5 % |
| | | | | | | |
| | | Total ARR (Annualized recurring revenue): | $ 22,503,820 | $ 21,293,669 | $ 1,210,151 | 5.7 % |
| | | | | | | |
| | Transaction Customers: | | | | | |
| | | Corporate customers | 981 | 1,002 | (21) | -2.1 % |
| | | Academic customers | 379 | 324 | 55 | 17.0 % |
| | | Total customers | 1,360 | 1,326 | 34 | 2.6 % |
Active Customer Accounts, Transactions and Annual Recurring Revenue
The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.
A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.
The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.
Use of Non-GAAP Measure – Adjusted EBITDA
The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):
| | | | | | | |
| | | | Quarter Ended | |||
| | | | 2026 | 2025 | Change | % Change |
| | Net Income (loss) | $ 765,252 | $ 749,387 | $ 15,865 | 2.1 % | |
| | Add (deduct): | | | | | |
| | | Other (income) expense | 55,604 | 191,053 | (135,449) | -70.9 % |
| | | Foreign currency translation loss (gain) | (8,541) | (17,256) | 8,715 | -50.5 % |
| | | Provision for income taxes | 100,019 | 21,231 | 78,788 | 371.1 % |
| | | Depreciation and amortization | 310,863 | 316,066 | (5,203) | -1.6 % |
| | | Stock-based compensation | (196,549) | 212,482 | (409,031) | -192.5 % |
| | Adjusted EBITDA | $ 1,026,648 | $ 1,472,963 | $ (446,315) | -30.3 % | |
About Research Solutions
Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com
Important Cautions Regarding Forward-Looking Statements
Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.
| Condensed Consolidated Balance Sheets (Unaudited) | ||||||
| | ||||||
| | | | | | ||
| | | 2026 | | 2026 | ||
| Assets | | | | | | |
| Current assets: | | | | | | |
| Cash and cash equivalents | | $ | 12,586,878 | | $ | 12,630,283 |
| Accounts receivable, net of allowance of | | | 6,649,615 | | | 6,963,040 |
| Prepaid expenses and other current assets | | | 633,216 | | | 689,548 |
| Prepaid royalties | | | 883,531 | | | 411,297 |
| Total current assets | | | 20,753,240 | | | 20,694,168 |
| | | | | | | |
| Non-current assets: | | | | | | |
| Property and equipment, net of accumulated depreciation of | | | 62,906 | | | 58,671 |
| Intangible assets, net of accumulated amortization of | | | 8,239,136 | | | 8,537,870 |
| | | | 16,372,979 | | | 16,372,979 |
| Deposits and other assets | | | 996 | | | 1,030 |
| Total assets | | $ | 45,429,257 | | $ | 45,664,718 |
| | | | | | | |
| Liabilities and Stockholders' Equity | | | | | | |
| Current liabilities: | | | | | | |
| Accounts payable and accrued expenses | | $ | 7,075,360 | | $ | 6,149,480 |
| Deferred revenue, current portion | | | 10,796,348 | | | 11,467,832 |
| Contingent earnout liability | | | 5,561,906 | | | 7,323,314 |
| Total current liabilities | | | 23,433,614 | | | 24,940,626 |
| | | | | | | |
| Non-current liabilities: | | | | | | |
| Deferred revenue, long-term portion | | | 7,157 | | | 17,245 |
| Total liabilities | | | 23,440,771 | | | 24,957,871 |
| | | | | | | |
| Commitments and contingencies | | | | | | |
| | | | | | | |
| Stockholders' equity: | | | | | | |
| Preferred stock; | | | — | | | — |
| Common stock; | | | 33,553 | | | 33,513 |
| Additional paid-in capital | | | 43,518,443 | | | 42,998,357 |
| Accumulated deficit | | | (21,456,373) | | | (22,221,625) |
| Accumulated other comprehensive loss | | | (107,137) | | | (103,398) |
| Total stockholders' equity | | | 21,988,486 | | | 20,706,847 |
| Total liabilities and stockholders' equity | | $ | 45,429,257 | | $ | 45,664,718 |
| Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) | ||||||
| | | | ||||
| | | Three Months Ended | ||||
| | | | ||||
| | | 2026 | | 2025 | ||
| | | | | | | |
| Revenue: | | | | | | |
| Platforms | | $ | 5,309,780 | | $ | 5,120,840 |
| Transactions | | | 6,601,733 | | | 7,191,345 |
| Total revenue | | | 11,911,513 | | | 12,312,185 |
| | | | | | | |
| Cost of revenue: | | | | | | |
| Platforms | | | 688,258 | | | 610,375 |
| Transactions | | | 4,842,275 | | | 5,476,512 |
| Total cost of revenue | | | 5,530,533 | | | 6,086,887 |
| Gross profit | | | 6,380,980 | | | 6,225,298 |
| | | | | | | |
| Operating expenses: | | | | | | |
| Selling, general and administrative | | | 5,149,242 | | | 4,947,561 |
| Depreciation and amortization | | | 310,863 | | | 316,066 |
| Total operating expenses | | | 5,460,105 | | | 5,263,627 |
| | | | | | | |
| Income from operations | | | 920,875 | | | 961,671 |
| | | | | | | |
| Other income | | | 93,608 | | | 126,913 |
| Accreted interest expense | | | (149,212) | | | (317,966) |
| | | | | | | |
| Income before provision for income taxes | | | 865,271 | | | 770,618 |
| Provision for income taxes | | | (100,019) | | | (21,231) |
| | | | | | | |
| Net income | | | 765,252 | | | 749,387 |
| | | | | | | |
| Other comprehensive income (loss): | | | | | | |
| Foreign currency translation | | | (3,739) | | | 967 |
| Comprehensive income | | $ | 761,513 | | $ | 750,354 |
| | | | | | | |
| Basic income per common share: | | | | | | |
| Net income per share | | $ | 0.02 | | $ | 0.02 |
| Weighted average common shares outstanding | | | 32,644,399 | | | 31,234,875 |
| | | | | | | |
| Diluted income per common share: | | | | | | |
| Net income per share | | $ | 0.02 | | $ | 0.02 |
| Weighted average common shares outstanding | | | 32,916,413 | | | 32,070,121 |
| Condensed Consolidated Statements of Cash Flows (Unaudited) | ||||||
| | | | | | | |
| | | Three Months Ended | ||||
| | | | ||||
| | | 2026 | | 2025 | ||
| | | | | | | |
| Cash flow from operating activities: | | | | | | |
| Net income | | $ | 765,252 | | $ | 749,387 |
| Adjustment to reconcile net income to net cash provided by operating activities: | | | | | | |
| Depreciation and amortization | | | 310,863 | | | 316,066 |
| Stock options expense | | | 90,556 | | | 58,706 |
| Restricted common stock expense (recovery due to forfeitures) | | | (287,105) | | | 153,776 |
| Accreted interest expense | | | 149,212 | | | 317,966 |
| Changes in operating assets and liabilities: | | | | | | |
| Accounts receivable | | | 313,425 | | | 292,053 |
| Prepaid expenses and other current assets | | | 56,332 | | | (140,004) |
| Prepaid royalties | | | (472,234) | | | (79,513) |
| Accounts payable and accrued expenses | | | 925,880 | | | 158,728 |
| Deferred revenue | | | (681,572) | | | (720,046) |
| Net cash provided by operating activities | | | 1,170,609 | | | 1,107,119 |
| | | | | | | |
| Cash flow from investing activities: | | | | | | |
| Purchase of property and equipment | | | (17,050) | | | (17,539) |
| Net cash used in investing activities | | | (17,050) | | | (17,539) |
| | | | | | | |
| Cash flow from financing activities: | | | | | | |
| Common stock repurchase | | | (10,039) | | | (23,387) |
| Payment of contingent acquisition consideration - Scite and FIZ | | | (1,183,906) | | | (1,337,857) |
| Net cash used in financing activities | | | (1,193,945) | | | (1,361,244) |
| | | | | | | |
| Effect of exchange rate changes | | | (3,019) | | | 115 |
| Net decrease in cash and cash equivalents | | | (43,405) | | | (271,549) |
| Cash and cash equivalents, beginning of period | | | 12,630,283 | | | 12,227,312 |
| Cash and cash equivalents, end of period | | $ | 12,586,878 | | $ | 11,955,763 |
| | | | | | | |
| Supplemental disclosures of cash flow information: | | | | | | |
| Cash paid for income taxes | | $ | 21,261 | | $ | 21,231 |
| | | | | | | |
| Non-cash investing and financing activities: | | | | | | |
| Contingent consideration accrual on asset acquisition | | $ | — | | $ | 29,117 |
| Common stock issued for Scite earnout payment | | $ | 726,714 | | $ | 726,714 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-first-quarter-fiscal-year-2027-results-302940963.html
SOURCE